Literature DB >> 35896278

Calamari, Hyperkalemia, and Renin-Angiotensin System Blockade.

Emily Janak1, Holly Kramer2,3,4.   

Abstract

Entities:  

Keywords:  ACE inhibitors; diabetes; hyperkalemia; renin angiotensin system

Mesh：

Substances：

Year:  2022        PMID： 35896278      PMCID： PMC9435975          DOI： 10.2215/CJN.07280622

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  10 in total

1.  Cardiac sensitivity to hyperkalemia in adrenalectomized dogs.

Authors:  N Hiatt; T Katayanagi; A Miller
Journal:  Proc Soc Exp Biol Med       Date:  1975-05

Review 2.  How Dangerous Is Hyperkalemia?

Authors:  John R Montford; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

3.  A brief historical perspective: Hodgkin and Huxley.

Authors:  Christof J Schwiening
Journal:  J Physiol       Date:  2012-06-01       Impact factor: 5.182

Review 4.  Relation of electrolyte disturbances to cardiac arrhythmias.

Authors:  C Fisch
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

5.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Authors:  J D Curb; S L Pressel; J A Cutler; P J Savage; W B Applegate; H Black; G Camel; B R Davis; P H Frost; N Gonzalez; G Guthrie; A Oberman; G H Rutan; J Stamler
Journal:  JAMA       Date:  1996-12-18       Impact factor: 56.272

6.  Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes.

Authors:  Yang Xu; Edouard L Fu; Marco Trevisan; Tomas Jernberg; Arvid Sjölander; Catherine M Clase; Juan-Jesus Carrero
Journal:  Am Heart J       Date:  2021-10-02       Impact factor: 4.749

7.  Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE Inhibitors.

Authors:  Toshiaki Ohkuma; Katie Harris; Mark Cooper; Diederick E Grobbee; Pavel Hamet; Stephen Harrap; Giuseppe Mancia; Michel Marre; Anushka Patel; Anthony Rodgers; Bryan Williams; Mark Woodward; John Chalmers
Journal:  Clin J Am Soc Nephrol       Date:  2022-07-27       Impact factor: 10.614

8.  Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.

Authors:  Silvia J Leon; Reid Whitlock; Claudio Rigatto; Paul Komenda; Clara Bohm; Ewa Sucha; Sarah E Bota; Meltem Tuna; David Collister; Manish Sood; Navdeep Tangri
Journal:  Am J Kidney Dis       Date:  2022-01-25       Impact factor: 11.072

9.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.